[
  {
    "ts": null,
    "headline": "4 Things You Need to Know if You Buy Moderna Stock Today",
    "summary": "It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020.  Despite its generating record sales and profits through 2022, early projections of sustained demand for coronavirus vaccinations failed to materialize, leading to a sharp drop in the business.  Here are five things you should know if you're considering buying Moderna stock now.",
    "url": "https://finnhub.io/api/news?id=eb044cfb1bfcb162200b679d489f7a58514ce17f505b43e6eea142a0dea86e3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742474700,
      "headline": "4 Things You Need to Know if You Buy Moderna Stock Today",
      "id": 133327503,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020.  Despite its generating record sales and profits through 2022, early projections of sustained demand for coronavirus vaccinations failed to materialize, leading to a sharp drop in the business.  Here are five things you should know if you're considering buying Moderna stock now.",
      "url": "https://finnhub.io/api/news?id=eb044cfb1bfcb162200b679d489f7a58514ce17f505b43e6eea142a0dea86e3d"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
    "summary": "Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.",
    "url": "https://finnhub.io/api/news?id=661997f746daf698d0000c7f7328d3e6c49fc655d722e02e6e14965810a8bc71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461970,
      "headline": "Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
      "id": 133325405,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.",
      "url": "https://finnhub.io/api/news?id=661997f746daf698d0000c7f7328d3e6c49fc655d722e02e6e14965810a8bc71"
    }
  }
]